Which has the lower trailing P/E, AMGN or NVS?

NVS has the lower trailing P/E: AMGN trades at 25.06 and NVS at 21.26. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AMGN or NVS?

Over the past five years, AMGN grew revenue faster — AMGN at a 8.39% CAGR versus NVS at 1.53%.

Does AMGN or NVS pay a bigger dividend?

AMGN yields 2.44% and NVS yields 3.38% based on trailing dividends and the latest price.

How have AMGN and NVS total returns compared?

Over the past 10 years, AMGN delivered 12.64% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Amgen Inc. (AMGN) vs Novartis AG (NVS)

A side-by-side comparison of Amgen Inc. and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

AMGN

Amgen Inc.

$217.61B

$403.20HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT

NVS

Novartis AG

$267.96B

$140.98HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT

Total return — AMGN vs NVS

growth of $100 · dividends reinvested · last 10y

AMGN +233.8% (+12.8%/yr)NVS +219.0% (+12.3%/yr)AMGN compounded faster over this window

AMGN NVS

AMGN vs NVS: by the numbers

•NVS is the larger company ($267.96B vs $217.61B market cap).
•NVS trades at the lower trailing earnings multiple (21.26 vs 25.06 P/E), one valuation lens rather than an overall verdict.
•AMGN grew revenue faster over the past five years (8.39% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 2.44%).

Metrics side by side

Valuation

Metric	AMGN	NVS
P/E ratio	25.06	21.26
Forward P/E	17.47	16.02
PEG ratio	8.52	1.38
P/S ratio	5.71	4.82
P/B ratio	18.62	6.45
EV / EBITDA	N/A	13.85
FCF yield	4.68%	5.90%

Profitability

Metric	AMGN	NVS
Gross margin	72.65%	74.44%
Operating margin	33.18%	30.54%
Net margin	22.93%	22.93%
ROE	74.80%	30.71%
ROIC	14.22%	13.93%

Dividends

Metric	AMGN	NVS
Dividend yield	2.44%	3.38%
Payout ratio	61.78%	71.50%

Growth (annualized)

Metric	AMGN	NVS
Revenue CAGR (5Y)	8.39%	1.53%
EPS CAGR (5Y)	2.94%	15.42%
FCF CAGR (5Y)	-3.91%	8.92%
Total return CAGR (5Y)	17.34%	16.96%

Frequently asked

Which has the lower trailing P/E, AMGN or NVS?: NVS has the lower trailing P/E: AMGN trades at 25.06 and NVS at 21.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AMGN or NVS?: Over the past five years, AMGN grew revenue faster — AMGN at a 8.39% CAGR versus NVS at 1.53%.
Does AMGN or NVS pay a bigger dividend?: AMGN yields 2.44% and NVS yields 3.38% based on trailing dividends and the latest price.
How have AMGN and NVS total returns compared?: Over the past 10 years, AMGN delivered 12.64% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMGN analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

Amgen P/E ratio Novartis AG P/E ratio Amgen dividend yield Novartis AG dividend yield Amgen ROE Novartis AG ROE Amgen operating margin Novartis AG operating margin Amgen revenue growth Novartis AG revenue growth Amgen free cash flow Novartis AG free cash flow

Amgen & Novartis AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.